Death receptor-ligand systems in cancer, cell death, and inflammation
about
Molecular crosstalk between apoptosis, necroptosis, and survival signalingUbiquitin-Mediated Regulation of Cell Death, Inflammation, and Defense of HomeostasisMarine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)The Janus Face of Death Receptor Signaling during Tumor ImmunoeditingLinear ubiquitination in immunityNovel CHOP activator LGH00168 induces necroptosis in A549 human lung cancer cells via ROS-mediated ER stress and NF-κB inhibitionEssential versus accessory aspects of cell death: recommendations of the NCCD 2015.TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis.H-Ras regulation of TRAIL death receptor mediated apoptosisThe use of a stably expressed FRET biosensor for determining the potency of cancer drugs.Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death.Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor.Actein Inhibits Cell Proliferation and Migration in Human Osteosarcoma.Cardiolipin or MTCH2 can serve as tBID receptors during apoptosisCaspase-8: not so silently deadly.Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review.Autophagy as a pro-death pathway.TRAIL-based therapy in pediatric bone tumors: how to overcome resistance.Surviving apoptosis: life-death signaling in single cells.Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities.Rational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignancies.Thermoregulation as a disease tolerance defense strategy.The cellular autophagy/apoptosis checkpoint during inflammation.A role for TRAIL/TRAIL-R2 in radiation-induced apoptosis and radiation-induced bystander response of human neural stem cellsAcquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis.Therapeutic applications of histone deacetylase inhibitors in sarcoma.Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.Silencing of karyopherin α2 inhibits cell growth and survival in human hepatocellular carcinomaInterleukin-10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by Streptococcus pneumoniae.Proapoptotic CD95L levels in normal human serum and sera of breast cancer patients.LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancerA validated, transitional and translational porcine model of hepatocellular carcinoma.Radiation-induced glioblastoma signaling cascade regulates viability, apoptosis and differentiation of neural stem cells (NSC).Marine Sponge Natural Products with Anticancer Potential: An Updated Review.JNK-signaling: A multiplexing hub in programmed cell death.Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.
P2860
Q26745680-E471F4DE-A17A-46F4-B002-F70F12B834E4Q26782575-1A9CDE18-753E-45FE-93F8-683B3D7EE84DQ26859211-CD60975D-37AC-434F-A9F9-9CB94999ABFDQ28070036-DB545A1D-AAB5-45C5-9B24-367E13BEB6D2Q28082899-29F3CACA-7DF0-439B-A572-BE9E08AE1BEEQ28822272-7B845026-ECB9-4F48-8B8E-CC1A4090E3A8Q30408769-CF01D522-86FD-40E4-8980-4FD27AC3D6C0Q33912038-7B1730C0-1827-480F-9A90-87B42570E241Q34104161-0BFED261-41ED-431A-A9B1-11AA1C2A02A3Q35238143-75FFD07F-C2E2-49ED-9A07-927465B1981CQ36125103-3906C37C-6791-41AE-8137-8FEA59C13763Q36600300-164078A3-ADBD-4F24-9A64-7384DF8EB754Q37032178-37DE4641-EB04-41F7-B429-F71B6C896D0CQ37098808-6FCB19D4-5162-4FC3-B913-992ED39D5DFEQ37625431-A7B11D08-AF83-4676-8682-CFF0EF78FBD0Q38178160-60792B88-67C8-4D33-A3E1-B879CD584C37Q38261558-469D624C-8DB9-493C-8A1F-9304E7319D60Q38352891-5FAF656E-F152-412B-8A10-C440B7DC18B2Q38446898-70D8CF6A-A7DE-45E4-91B8-AC966387BC39Q38503469-7A8DE240-947A-4664-BA00-30299729D4D7Q38575137-992CE519-056C-44CB-8891-BC50EC900B42Q38637652-00A27A73-B52A-4188-B534-4A19C0C6DF37Q38999142-BEC355B6-8B45-4356-B037-9C567E77C97DQ39005984-F205208A-18CC-469C-8205-6BE05BA4BB83Q39070728-E3FF3694-EADF-4EA6-B853-3C3A7332C15CQ39247899-8F42C2A9-3E64-4860-A537-AACD8EA54A27Q39297992-C7A63995-0A0D-4A85-94BD-B222C6DAEF6EQ39450827-F92FE923-F085-4938-967B-5071C647E587Q39767815-948023BF-B7B3-4865-9C43-FA97084A9584Q41055921-8CE80191-6E10-4592-ACB7-1548C505AF37Q41191945-78545A45-4901-4514-B421-D25DDB3AD290Q41626977-13CF4DD2-DC91-4AC8-B364-9B8378D209D4Q41949682-F22CB598-42A1-470D-8899-195C01EFB5DFQ41985448-62AF9867-A26F-4EED-8EA8-7EF32BFAA7C8Q42117551-7828CE49-03A2-4893-A37A-70613040E472Q43245354-2CFAC39A-72FC-4189-BE0E-93B3009B1E26Q47095837-89208E79-83AC-4D60-8F49-1D245B658177Q47742909-F42CB765-B5A6-4DB9-A04A-2DF001E9F1A3Q50133227-CFE9F45B-68A8-4609-BE06-E31B856B7D7CQ50134139-981481F7-9ADD-4647-8BA2-8427406E064F
P2860
Death receptor-ligand systems in cancer, cell death, and inflammation
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Death receptor-ligand systems in cancer, cell death, and inflammation
@ast
Death receptor-ligand systems in cancer, cell death, and inflammation
@en
Death receptor-ligand systems in cancer, cell death, and inflammation
@nl
type
label
Death receptor-ligand systems in cancer, cell death, and inflammation
@ast
Death receptor-ligand systems in cancer, cell death, and inflammation
@en
Death receptor-ligand systems in cancer, cell death, and inflammation
@nl
prefLabel
Death receptor-ligand systems in cancer, cell death, and inflammation
@ast
Death receptor-ligand systems in cancer, cell death, and inflammation
@en
Death receptor-ligand systems in cancer, cell death, and inflammation
@nl
P2860
P3181
P1476
Death receptor-ligand systems in cancer, cell death, and inflammation
@en
P2093
H. Walczak
P2860
P304
P3181
P356
10.1101/CSHPERSPECT.A008698
P407
P577
2013-05-01T00:00:00Z